Autologous Adipose-Derived SVF (Stromal Vascular Fraction) for Osteoarthritis
Study Summary
This trial is testing whether it is safe and feasible to inject a person's own fat-derived cells into their knee to treat osteoarthritis.
- Osteoarthritis of the Knee
Treatment Effectiveness
Effectiveness Progress
Similar Trials
Study Objectives
1 Primary · 0 Secondary · Reporting Duration: 2 years
Trial Safety
Safety Progress
Similar Trials
Trial Design
2 Treatment Groups
SVF (Stromal Vascular Fraction) Group
1 of 2
Placebo Group
1 of 2
Experimental Treatment
Non-Treatment Group
30 Total Participants · 2 Treatment Groups
Primary Treatment: Autologous Adipose-Derived SVF (Stromal Vascular Fraction) · Has Placebo Group · Phase 1
Trial Logistics
Trial Timeline
Who is running the clinical trial?
Eligibility Criteria
Age 40 - 70 · All Participants · 11 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you:Frequently Asked Questions
Does this experimental procedure require subjects to be of a particular age?
"This research is open to those aged 40 or older but not exceeding the age of 70." - Anonymous Online Contributor
How many individuals have volunteered for this experiment?
"Affirmative. The clinical trial is actively in session, as per the information on clinicaltrials.gov; it was first introduced on July 1st 2019 and last updated on May 26th 2022. 30 participants will be accepted at 2 different locations for this medical study." - Anonymous Online Contributor
Are there any vacancies left for participants in this clinical experiment?
"Indeed, clinicaltrials.gov displays that this trial is currently seeking participants - it was posted on July 1st 2019 and last updated on May 26th 2022. Specifically, the study requires 30 subjects across 2 locations to be recruited." - Anonymous Online Contributor
To whom is this research open for participation?
"This clinical trial requires 30 participants, within the ages of 40 to 70 who suffer from arthrosis. Other prerequisites for enrolment include: Females with childbearing potential must take a pregnancy test and use adequate contraception (hormonal or barrier method or abstinence) between screening and 1 year after drug treatment ends; females with childbearing potential are defined as either premenopausal without sterilization surgery, or post-menopausal for less than 2 years; urine tests will be conducted prior to administering study drugs while serum tests can be done at a central lab; candidates should also have no issues walking unaided by any device such as walkers" - Anonymous Online Contributor
Could you elucidate the potential risks associated with Autologous Adipose-Derived SVF (Stromal Vascular Fraction) treatments?
"There is limited data backing Autologous Adipose-Derived SVF's safety and efficacy, thus it received a score of 1." - Anonymous Online Contributor